Similarities and perspectives on the two C's-Cancer and COVID-19

COVID-19 continues to dominate the health-care burden in the twenty-first century. While health-care professionals around the world try their best to minimize the mortality from this pandemic, we also continue to battle the high mortality from different types of cancer. For the hemostasis and thrombosis specialist, these two conditions present some unusual similarities including the high rate of thrombosis and marked elevation of D-dimers. In this forum article, we discuss these similarities and provide some considerations for future research and therapeutic trials.

Automated summary

COVID-19 and cancer continue to pose significant challenges in healthcare, with both conditions sharing similarities such as high rates of thrombosis and marked elevation of D-dimers. Hemostasis and thrombosis specialists need to study these similarities and provide insights for future research and therapeutic trials.